Exova SL Pharma Information

Contact top employees from Exova SL Pharma

Summary

Exova SL Pharma is a private company that has been in the industry for 29 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Medical Research & Laboratories areas. The position of the President is occupied by Waheed Sheikh. Its headquarters is located at Wilmington, Delaware, USA. The number of employees ranges from 25 to 100. The annual revenue of Exova SL Pharma varies between 5.0M and 25M. To connect with Exova SL Pharma employee register on SignalHire.

Organization Website

slpharmalabs.com

Social Links

linkedIn

Phone Number

302-636-0202

Industries

Headquarters Location

1300 First State Blvd., Ste C, Wilmington, DE, 19804 US

Employees Size

10-50 employees

SIC Code

2834, 8731

DMA Code

Delaware Valley

Founded

1997

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Subsidiary

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Exova SL Pharma shows a diverse range of experience levels:
7% for 5–7 years29% for 8–10 years64% have over 11 years of service at Exova SL Pharma
Contact top employees from Exova SL Pharma

FAQ

Exova SL Pharma operates in the Pharma industries. More details can be found on the official website: slpharmalabs.com.
The headquarters of Exova SL Pharma are located in Wilmington, United States.
The current CEO of Exova SL Pharma is Waheed Sheikh
You can contact Exova SL Pharma by phone at 302-636-0202.
Exova SL Pharma currently employs 10-50 people.
Exova SL Pharma's revenue is approximately 7M.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP